Companion Diagnostics Market By Indication (Oncology, Cardiovascular Diseases, Infectious Diseases, Autoimmune Diseases), By Technology (Polymerase Chain Reaction, Immunohistochemistry (IHC), In-Situ Hybridization Test (ISH), Gene Sequencing, Others) - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 – 2023

Companion diagnostic tests are used to identify suitable patients for administering specific drugs and monitoring the prognosis of drug effects on the disease. This concept of combining a drug with a diagnostic test is known as predictive medicine or personalized medicine. A companion diagnostic test has the ability to predict the risks of the disease and monitor its therapeutic response. The tests enable physicians to make decisions on the type of drugs and dosage administration and thereby reduce the mortality rates associated with diseases such as cancer and neurodegenerative disorders. The global companion diagnostics market is expected to witness significant growth during the forecast period primarily by the growing focus on cost cutting in drug discovery and development. Asia Pacific is expected to grow at a highest rate during the forecast period due increased adoption, technological advancements, and demand for personalized medicine. Vendors in the market are focusing on several strategies such as licensing agreements, collaborations, and partnership activities to develop highly specific molecular diagnostic tests to monitor or select target therapeutics for addressing the pathogenesis of major diseases.

The report titled “Companion Diagnostics Market- Growth, Share, Opportunities and Competitive Analysis, 2016–2023” offers strategic insights into the overall companion diagnostics market along with the market size and estimates for the duration 2016 to 2023. The said research study covers in-depth analysis of multiple market segments based on type of indication, type of technologies and different geographical region. The indication type segment studied for analyzing the overall companion diagnostics market are oncology, cardiovascular diseases, virology and autoimmune diseases. On the basis of technology the companion diagnostics market has been segmented into polymerase chain reaction, immunohistochemistry, In-situ hybridization test, gene sequencing and others. In order to help strategic decision makers, the report also includes competitive profiling of the leading players in companion diagnostics market, attractive investment proposition and Porter’s five forces model, and market positioning of key manufacturers sections. Other in-depth analysis provided in the report includes:

Geographically, the Companion Diagnostics Market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Rest of Asia-Pacific
  • Latin America
  • Middle East and Africa

Market size and forecast for these regional and country level markets are presented in this study for the period 2013-2023. Market growth rates for the forecast period 2016-2023 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global companion diagnostics market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global companion diagnostics market. This report concludes with company profiles section that highlights major information about the key players engaged in companion diagnostics market. In-depth competitive environment analysis and historical years (2013 & 2014) market size data are also provided in the report.

Thus, the research study provides a holistic view of the treatment global companion diagnostics market, offering market size and estimates for the period from 2016 to 2023, keeping in mind the above-mentioned factors.

Companion Diagnostics Market

 

For the purpose of this study, the global companion diagnostics market is categorized as follows:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa

Companion Diagnostics Market

The geographical segmentation of the global companion diagnostics market comprises North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. In base year 2015, North America accounted for the largest market in the global companion diagnostics. In North America, the US represented the largest market for companion diagnostic tests. This is mainly attributed to the growing demand for targeted therapeutics and the increase in the prevalence of the pathogenesis of various cancer ailments. In short, the demand for personalized medicines and diagnostics is driving the adoption of companion diagnostics. However, stringent regulations are expected to limit the growth of the market and delay the launch of various products. Asia Pacific is expected to grow at a highest rate during the forecast period due increased adoption, technological advancements, and demand for personalized medicine. Vendors in the market are focusing on several strategies such as licensing agreements, collaborations, and partnership activities to develop highly specific molecular diagnostic tests to monitor or select target therapeutics for addressing the pathogenesis of major diseases. Moreover, the increase in the prevalence of cancer and associated disorders, the increase in healthcare expenditure, and the increase in the level of awareness among the population. Thus, the APAC region is expected to adopt companion diagnostics tests at a rapid rate during the forecast period.

Choose License Type
Published Date:  Sep 2016
Category:  Medical Devices
Report ID:   58078
Report Format:   PDF
Pages:   120
Rating:    4.3 (60)
Connect With Us
+1-408-641-3282
24/7 Research Support